Skip to main content
Log in

Slow-Release Doxorubicin Pellets Generate Myocardial Cardiotoxic Changes in Mice Without Significant Systemic Toxicity

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

An increasing volume of pre-clinical and clinical-translational research is attempting to identify novel biomarkers for improved diagnosis and risk-stratification of chemotherapy-induced cardiotoxicity. Most published animal models have employed weekly intraperitoneal injections of doxorubicin to reach a desired cumulative dose. This approach can be associated with severe systemic toxicity which limits the animal model usefulness, particularly for advanced imaging. In the current study, slow-release subcutaneous doxorubicin pellets demonstrated histopathologic evidence of cardiotoxicity at doses similar to standard human dose-equivalents without limiting animal survival or ability to participate in advanced imaging studies. This approach may provide a more robust cardiotoxicity animal model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

CMR:

Cardiac magnetic resonance imaging

PET:

Positron emission tomography

IP:

Intraperitoneal

TUNEL:

Terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling

References

  1. Lotrionte, M., Biondi-Zoccai, G., Abbate, A., Lanzetta, G., D’Ascenzo, F., Malavasi, V., et al. (2013). Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. The American Journal of Cardiology, 112(12), 1980–1984. https://doi.org/10.1016/j.amjcard.2013.08.026.

    Article  CAS  PubMed  Google Scholar 

  2. Chatterjee, K., Zhang, J., Honbo, N., & Karliner, J. S. (2010). Doxorubicin Cardiomyopathy. Cardiology, 115(2), 155–162. https://doi.org/10.1159/000265166.

    Article  CAS  PubMed  Google Scholar 

  3. Jiji, R. S., Kramer, C. M., & Salerno, M. (2012). Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs. Journal of Nuclear Cardiology, 19(2), 377–388. https://doi.org/10.1007/s12350-012-9512-2.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Farhad, H., Staziaki, P. V., Addison, D., Coelho-Filho, O. R., Shah, R. V., Mitchell, R. N., et al. (2016). Characterization of the changes in cardiac structure and function in mice treated with anthracyclines using serial cardiac magnetic resonance imaging. Circulation: Cardiovascular Imaging, 9(12), 2. https://doi.org/10.1161/circimaging.115.003584.

    Article  Google Scholar 

  5. Pokrzywinski, K. L., Biel, T. G., Rosen, E. T., Bonanno, J. L., Aryal, B., Mascia, F., et al. (2018). Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17beta-estradiol in female tumor-bearing spontaneously hypertensive rats. Biology of Sex Differences, 9(1), 25. https://doi.org/10.1186/s13293-018-0183-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by Northwestern University’s Center for Advanced Microscopy and a Cancer Center Support Grant (NCI CA060553). Histology services were provided by the Northwestern University Mouse Histology and Phenotyping Laboratory which is supported by NCI P30-CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. The authors also acknowledge Quanhong Grace Ma, Research Lab Manager, Northwestern University Department of Radiology for her contributions to this project.

Funding

This work was funded by an RSNA Resident Research Grant (RR1602).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bradley D. Allen.

Ethics declarations

Conflicts of interest

JCC has a research relationship with Siemens, and reports travel/accommodations expenses reimbursed by Siemens. All additional authors have no disclosures.

Ethical Approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Additional information

Handling Editor: Y. James Kang.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allen, B.D., Zhang, Z., Naresh, N.K. et al. Slow-Release Doxorubicin Pellets Generate Myocardial Cardiotoxic Changes in Mice Without Significant Systemic Toxicity. Cardiovasc Toxicol 19, 482–484 (2019). https://doi.org/10.1007/s12012-019-09521-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-019-09521-0

Keywords

Navigation